| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.26B | 49.38B | 42.22B | 34.91B | 29.75B | 24.52B |
| Gross Profit | 19.65B | 19.20B | 16.29B | 13.62B | 11.86B | 9.74B |
| EBITDA | 11.03B | 10.45B | 8.48B | 6.47B | 5.24B | 4.49B |
| Net Income | 5.88B | 5.53B | 4.52B | 3.15B | 2.73B | 2.36B |
Balance Sheet | ||||||
| Total Assets | 35.42B | 35.41B | 32.54B | 29.00B | 25.34B | 20.47B |
| Cash, Cash Equivalents and Short-Term Investments | 2.96B | 2.34B | 2.18B | 2.03B | 2.18B | 1.67B |
| Total Debt | 7.31B | 5.00B | 6.71B | 7.73B | 7.30B | 4.40B |
| Total Liabilities | 16.25B | 15.09B | 15.75B | 15.32B | 13.58B | 9.97B |
| Stockholders Equity | 18.80B | 19.96B | 16.53B | 13.51B | 11.66B | 10.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.63B | 3.32B | 1.60B | 1.43B | 498.26M |
| Operating Cash Flow | 0.00 | 5.64B | 5.28B | 4.25B | 3.01B | 3.02B |
| Investing Cash Flow | 0.00 | -1.52B | -2.84B | -3.51B | -3.28B | -3.95B |
| Financing Cash Flow | 0.00 | -3.96B | -2.53B | -954.30M | 765.20M | 1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥55.73B | 20.65 | ― | 3.33% | 9.63% | 11.40% | |
75 Outperform | ¥37.16B | 9.65 | 10.19% | 3.21% | 6.55% | 5.32% | |
71 Outperform | ¥11.77B | 14.99 | ― | 1.08% | 18.17% | 191.50% | |
67 Neutral | ¥22.16B | 14.17 | ― | 1.34% | 16.06% | 31.24% | |
64 Neutral | ¥9.94B | 35.99 | ― | 3.65% | 16.07% | 50.91% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥283.52B | 44.54 | ― | 0.87% | 16.30% | 23.34% |